Companion Animal Health Market Size, Share & Industry | 2032

Companion Animal Health Market Size, Share & Industry | 2032

Segments - Companion Animal Health Market by Product (Pharmaceuticals, Vaccines, Diagnostics, Feed Additives, and Others), Animal Type (Cats, Dogs, Equine, and Others), Distribution Channel (E-commerce, Retail, and Hospital Pharmacies), End-user (Hospitals, Point-of-care/In-house Testing, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-6483 | 4.7 Rating | 76 Reviews | 224 Pages | Format : PDF Excel PPT

Report Description


Companion Animal Health Market Outlook 2032

The global companion animal health market size was USD 22.8 Billion in 2023 and is projected to reach USD 51.1 Billion by 2032, expanding at a CAGR of 9.4% during 2024–2032. The market growth is attributed to the increasing awareness about pet health among pet owners.

Growing awareness among pet owners regarding preventive healthcare measures for companion animals is resulting in a high demand for veterinary healthcare services, which further boosts the market. Veterinarians are increasingly incorporating advanced veterinary healthcare solutions to ensure the health and well-being of pets. Moreover, the global rise in companion animal ownership is driving the demand for effective veterinary healthcare solutions.

  • According to the report published by Forbes on January 25, 2024, approximately 29% of households across the US own cats.

Companion Animal Health Market Outlook

Impact of Artificial Intelligence (AI) on the Companion Animal Health Market

The emergence of artificial intelligence is likely to boost the companion animal health market. AI solutions facilitate early detection of diseases and personalized treatment plans, improving patient outcomes and enhancing the quality of care. Additionally, AI-powered imaging and diagnostic tools have enhanced diagnostic accuracy and efficiency, enabling rapid and precise identification of health conditions in companion animals.

Companion Animal Health Market Dynamics

Companion Animal Health Market Dynamics

Major Drivers

Increasing pet ownership rates are anticipated to drive the market during the forecast period. Furthermore, the growing awareness of the importance of pet healthcare and preventive healthcare measures among pet owners is boosting the demand for companion animal healthcare products and services. The rising number of pet owners across the globe is expected to boost the market in the coming years.

  • According to Pet Ownership Statistics 2024, the number of US households owning pets increased from 73 million in 2010 to 87 million in 2022.

Existing Restraints

Rising cost of veterinary services and medications hinders the market. The affordability of veterinary care is becoming a concern for pet owners, particularly those with limited financial resources. Moreover, the regulatory challenges associated with companion animal health product approvals further hamper the market.

Emerging Opportunities

­Increasing investments in research & development (R&D) within the veterinary healthcare sector create immense opportunities for players competing in the market. These investments enable the exploration of advanced technologies, such as genomics, biotechnology, and digital health solutions, to improve diagnostic accuracy, treatment efficacy, and overall patient outcomes. Furthermore, the rising demand for personalized and specialized veterinary healthcare services propels the market during the projected period.

Scope of the Companion Animal Health Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Attributes

Details

Report Title

Companion Animal Health Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2023

Historic Data

2017 -2022

Forecast Period

2024–2032

Segmentation

Product (Pharmaceuticals, Vaccines, Diagnostics, Feed Additives, and Others), Animal Type (Cats, Dogs, Equine, and Others), Distribution Channel (E-commerce, Retail, and Hospital Pharmacies), and End-user (Hospitals, Point-of-care/In-house Testing, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

ADM; BASF SE; Ceva; Bayer AG; Elanco; HACARUS INC; Merck & Co., Inc; Nutreco; PETIA VET HEALTH; Thermo Fisher Scientific Inc; Vetoquinol; Virbac; and Zoetis Services LLC


Regional Outlook

In terms of region, the global companion animal health market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to the high ownership of companion animals in the region. For instance, as per the Pet Ownership Statistics 2024, about 66% of households in the US, which means 86.9 million homes, have at least one pet. Moreover, the presence of major pharmaceutical companies specializing in veterinary medicine contributes to the market growth in the region.

The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to the increasing number of households owning pets. Furthermore, the growing awareness of pet health and wellness among pet owners and the rising availability of pet insurance and preventive healthcare services are projected to fuel the market during the forecast period.

Companion Animal Health Market Region

Companion Animal Health Market Segment Insights

Product Segment Analysis

Based on product, the market is divided into pharmaceuticals, vaccines, diagnostics, feed additives, and others. The pharmaceuticals segment held a major share of the market in 2023, due to the high prevalence of chronic and infectious diseases among companion animals.

Pharmaceuticals are important in managing various health conditions in companion animals, including arthritis, diabetes, cardiovascular diseases, and infectious diseases. Additionally, the easy availability of pharmaceutical products and specialty medications boosts the segment.

The vaccines segment is expected to expand at a significant growth rate in the coming years, owing to the increasing awareness of the importance of vaccination in preventing infectious diseases. Furthermore, the development of improved vaccines with enhanced efficacy, safety, and duration of immunity is expected to propel the segment in the coming years.

Companion Animal Health Market Product

Animal Type Segment Analysis

On the basis of animal type, the global market is segregated into cats, dogs, equine, and others. The dogs segment held a large market share in 2023, due to the increasing ownership of dogs as companion animals across the globe. Dogs are susceptible to a wide range of health conditions, including infectious diseases, orthopedic issues, and age-related ailments, which boost the demand for specialized veterinary treatments and medications. Additionally, the increasing trend of pet humanization, where dogs are regarded as family members, boosts the adoption of premium healthcare products and services.

The cats segment is anticipated to expand at a substantial CAGR during the forecast period, owing to the increasing popularity of cats as pets. This, in turn, boosts the demand for regular veterinary care and medical services. Moreover, the increasing awareness of the unique healthcare needs of cats and advancements in feline medicine and nutrition are boosting the segment.

Companion Animal Health Market Animal Type

Distribution Channel Segment Analysis

Based on distribution channel, the companion animal health market is segmented into e-commerce, retail, and hospital pharmacies. The e-commerce segment is projected to register a robust growth rate during the assessment years, due to the increasing adoption of online platforms for purchasing branded pet products. E-commerce platforms offer pet owners the convenience of browsing and purchasing companion animal health products from the comfort of their homes. Moreover, e-commerce platforms offer personalized recommendations to tailor product offerings to individual pet owners, which boosts the segment.

End-user Segment Analysis

On the basis of end-user, the market is divided into hospitals, point-of-care/in-house testing, and others. The point-of-care segment is expected to dominate the market in terms of revenue generation during the projection period, owing to the increasing demand for quick and convenient diagnostic solutions. Point-of-care testing provides quick results, allowing veterinarians to make timely treatment decisions and improve patient outcomes. Additionally, the growing availability of portable and user-friendly diagnostic devices and expanding veterinary training programs on point-of-care testing techniques are further fueling the segment.

Segments

The companion animal health market has been segmented on the basis of

Product

  • Pharmaceuticals
  • Vaccines
  • Diagnostics
  • Feed Additives
  • Others

Animal Type

  • Cats
  • Dogs
  • Equine
  • Others

Distribution Channel

  • E-commerce
  • Retail
  • Hospital Pharmacies

End-user

  • Hospitals
  • Point-of-care/In-house Testing
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • ADM
  • BASF SE
  • Ceva
  • Bayer AG
  • Elanco
  • HACARUS INC
  • Merck & Co., Inc
  • Nutreco
  • PETIA VET HEALTH
  • Thermo Fisher Scientific Inc
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

Competitive Landscape

Key players competing in the global companion animal health market are ADM; BASF SE; Ceva; Bayer AG; Elanco; HACARUS INC; Merck & Co., Inc; Nutreco; PETIA VET HEALTH; Thermo Fisher Scientific Inc; Vetoquinol; Virbac; and Zoetis Services LLC.

These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instances,

  • On March 11, 2022, HACARUS INC, a prominent technology solutions provider, launched its ECG platform in collaboration with DS Pharma Animal Health. This platform is tailored to analyze and assess the heart condition of dogs, aiding in the early identification of cardiac diseases, which stand as the second major cause of death for canines.

    Companion Animal Health Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Companion Animal Health Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Companion Animal Health Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Companion Animal Health Market - Supply Chain
  4.5. Global Companion Animal Health Market Forecast
     4.5.1. Companion Animal Health Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Companion Animal Health Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Companion Animal Health Market Absolute $ Opportunity
5. Global Companion Animal Health Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Companion Animal Health Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Point-of-care/In-house Testing
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Companion Animal Health Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Companion Animal Health Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Companion Animal Health Demand Share Forecast, 2019-2026
7. North America Companion Animal Health Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Companion Animal Health Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Companion Animal Health Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Point-of-care/In-house Testing
     7.4.3. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Companion Animal Health Demand Share Forecast, 2019-2026
8. Latin America Companion Animal Health Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Companion Animal Health Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Companion Animal Health Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Point-of-care/In-house Testing
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Companion Animal Health Demand Share Forecast, 2019-2026
9. Europe Companion Animal Health Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Companion Animal Health Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Companion Animal Health Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Point-of-care/In-house Testing
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Companion Animal Health Demand Share Forecast, 2019-2026
10. Asia Pacific Companion Animal Health Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Companion Animal Health Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Companion Animal Health Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Point-of-care/In-house Testing
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Companion Animal Health Demand Share Forecast, 2019-2026
11. Middle East & Africa Companion Animal Health Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Companion Animal Health Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Companion Animal Health Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Point-of-care/In-house Testing
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Companion Animal Health Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Companion Animal Health Market: Market Share Analysis
  12.2. Companion Animal Health Distributors and Customers
  12.3. Companion Animal Health Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. ADM
     12.4.2. BASF SE
     12.4.3. Ceva
     12.4.4. Bayer AG
     12.4.5. Elanco
     12.4.6. HACARUS INC
     12.4.7. Merck & Co., Inc
     12.4.8. Nutreco
     12.4.9. PETIA VET HEALTH
     12.4.10. Thermo Fisher Scientific Inc
     12.4.11. Vetoquinol
     12.4.12. Virbac
     12.4.13. Zoetis Services LLC

Methodology

Our Clients

sinopec
General Electric
The John Holland Group
Dassault Aviation
Nestle SA
Microsoft
Deloitte
General Mills